MSB 11.7% $1.29 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-849

  1. 15,474 Posts.
    lightbulb Created with Sketch. 5573
    and now the FDA say they think they had what they needed all along.

    In that case (pun intended), the CA lawyers must be in a panic (not that I ever thought they had a valid case in the first place) …. LMAO

    I would rather the BLA resubmission is water tight this time around as I believe we will receive a 2 month PDUFA date so I am ok with it being lodged in late June


    GLTAH
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.29
Change
0.135(11.7%)
Mkt cap ! $1.341B
Open High Low Value Volume
$1.15 $1.33 $1.15 $17.77M 14.27M

Buyers (Bids)

No. Vol. Price($)
12 33174 $1.29
 

Sellers (Offers)

Price($) Vol. No.
$1.29 26620 7
View Market Depth
Last trade - 15.22pm 23/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.